The excitement surrounding cell and gene therapies predominantly stems from their potential to treat and cure diseases previously considered untreatable. This includes rare diseases, hematopoietic disorders as well as various types of cancer.
Advances in gene and cell therapy include customized treatment options where the therapeutic modality aims to
Either way, the potential to translate into better healthcare for patients is immense.
However, the increasing biological complexity of cell and gene therapy calls for improved solutions and workflows that can help bring life-saving treatments to patients faster and make novel cures safer, more effective, durable, and affordable.
Together, we can help deliver and execute on your cell and gene therapy efforts. Our solutions range from functional genomics, gene editing, payload design, and vector optimization to cell analysis, cell counting and imaging, and bespoke personalized services.
Optimize Your Gene Therapy Workflows
Gene therapies can either restore gene function, modulate protein expression, or edit/silence a gene to treat a disease at the genetic level.
In vivo gene editing uses a delivery vehicle such as a virus, for example an adeno-associated virus (AAV), or a non-viral nanoparticle which can target the gene of interest to the disease-associated tissue or organ.
We offer enablement and transformative solutions for your gene therapy discovery, development, and manufacturing processes:
Elevate Your Cell Therapy Programs
Depending on availability, immunocompatibility, and sample source, cell-based therapies can be segmented into two categories: autologous and allogenic.
Autologous therapies are customized to an individual patient’s needs, in which cells are enriched, modified, and injected back into the same individual to elicit a desired immunotherapeutic response.
In allogeneic cell-based therapies, cells or tissue (e.g., bone marrow, adipose fat) from unrelated donors are banked in large batches using Good Manufacturing Practices (GMP) to treat larger patient populations.
We offer enablement and transformative cellular therapy products for your discovery, development, and scale up processes: